GeneDx Holdings (WGS) Net Cash Flow (QoQ) (2020 - 2026)
Powered by 
Analysis
GeneDx Holdings (WGS) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -203.49% |
| Mar 31, 2026 | -222.61% |
| Dec 31, 2025 | -58.66% |
| Sep 30, 2025 | 185.40% |
| Jun 30, 2025 | -276.54% |
| Mar 31, 2025 | -46.96% |
| Dec 31, 2024 | 1,402.81% |
| Sep 30, 2024 | 106.59% |
| Jun 30, 2024 | -72.40% |
| Mar 31, 2024 | -229.29% |
| Dec 31, 2023 | 117.87% |
| Sep 30, 2023 | -20.71% |
| Jun 30, 2023 | -174.88% |
| Mar 31, 2023 | 213.66% |
| Dec 31, 2022 | 27.72% |
| Sep 30, 2022 | -452.48% |
| Jun 30, 2022 | 80.27% |
| Mar 31, 2022 | -40.95% |
| Dec 31, 2021 | -114.29% |
| Sep 30, 2021 | 1,421.41% |